Compound Screening and Drug Discovery

  • Primary cancer cells and 3D organoids.
  • Cell-based assay development:
  • Design and optimize assays to evaluate compound effects on cell viability, proliferation, and function.
  • High-throughput screening of compounds of interest:
  • Test large compound libraries for anticancer activity using automated systems.
  • Hit identification and validation:
  • Confirm and characterize hits from primary screens using secondary assays and mechanistic studies.